Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126519) titled 'A Study on the Safety and Effectiveness of Relafenopride a in Real-World Clinical Practice' on June 10.
Study Type: Observational study
Study Design:
Factorial
Primary Sponsor: Shandong Provincial Hospital
Condition:
locally advanced/recurrent or metastatic gastric cancer
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-06-15
Target Sample Size: Based on the patient's tumor type, stage, and previous treatment history, participants will be enrolled into one of three different treatment regimen groups:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr...